P53 is inactivated in tumors by mechanisms other than mutations in the p53 gene itself. To gain insight into the mechanisms by which this inactivation occurs, we chemically mutagenized A1-5 cells expressing high levels of temperature sensitive p53 val135 (tsp53) and selected for clones that were capable of growth at the permissive temperature for p53 activation. We expanded 22 clones (ALTR cells for A1-5 Low Temperature Resistant) that could grow at the permissive temperature. Most exhibited cytoplasmic sequestration as the mechanism by which p53 was inactivated. We show here that this cytoplasmically sequestered tsp53 protein is maintained in a mutant conformation. Only in clones with nuclear localized p53 is it also expressed in the wild-type conformation suggesting that subcellular localization of tsp53 is important in determining the conformation of the protein. Consistent with this, we show that the changes in conformation of p53 in A1-5 and SK-N-SH cells induced by ionizing radiation also correlate with nuclear translocation of p53. We suggest that nuclear translocation of p53 can result in a change in the conformation from mutant to wild-type but that these may be two separable events. Oncogene (2000) 19, 4042 ± 4049.
Introduction
The p53 tumor suppressor plays a crucial role in the maintenance of genomic stability by transcriptionally activating genes involved in DNA repair, growth arrest and apoptosis (Levine, 1997; Levine et al., 1994) . P53 is activated by genotoxic agents and although the events involved in the activation of p53 are not well understood, the process is thought to be a complicated one, involving the stabilization of the protein (Kubbutat and Vousden, 1998) , its translocation into the nucleus (Shaulsky et al., 1991b,c) , and tetramerization (McLure and Lee, 1998) , all of which are important steps in the process that lead to its activation for DNA binding and induction of target gene expression. P53 function is lost in over 50% of all human cancers which leads to genetic instability and neoplastic progression (Nigro et al., 1989) . P53 is inactivated primarily as a consequence of mutations in the p53 gene itself. However, other mechanisms have been described which can also nullify the activity of the p53 protein. These include interaction with viral antigens (Schener et al., 1990) and cellular proteins which lead to enhanced degradation of p53 (Brown and Pagano, 1997; Haupt et al., 1997) , and by physically sequestering the protein in the cytoplasmic compartment of cells (Goldman et al., 1996; Moll et al., 1996) . Interestingly, in this latter case, p53 can be induced to enter the nucleus in response to ionizing radiation and induce the expression of downstream target genes. Cytoplasmic sequestration of p53 has been observed in neuroblastomas, breast and colon cancers suggesting that this mechanism may be important in the development of these tumors (Bosari et al., 1995; Moll et al., 1992 Moll et al., , 1995 .
At the biochemical level, one feature that is critical for normal function is a wild-type conformation of the p53 protein (Wolkowicz et al., 1998) . Mutations in the p53 gene frequently lead to the expression of an inactive protein with a mutant conformation that can be detected by mutant protein speci®c antibodies such as PAb 240 (Gannon et al., 1990; Stephen and Lane, 1992) . Hainaut and Milner (1993) demonstrated that metal chelators such as 1,10-phenanthroline could perturb the wild-type conformation of p53 (246+) to a mutant (240+) conformation, which also led to the inhibition of its ability to bind DNA in electrophoretic mobility shift assays. Recent data suggests that tumor growth can be inhibited by pharmacological agents that reverse the mutant conformation of p53 to the wild-type functional conformation (Foster et al., 1999) . Nevertheless, there is evidence that the wild-type protein can also undergo changes in conformation during normal cell function (Milner, 1991a (Milner, ,b, 1994 Milner and Watson, 1990; Sabapathy et al., 1997; Shaulsky et al., 1991a) . For example, genotypically wild-type p53 found in a mutant conformation promotes cell growth, and only behaves as a tumor suppressor when present in the wild-type conformation (Milner and Watson, 1990; Sabapathy et al., 1997) . In addition, wild-type p53 bound to DNA has been shown to be recognizable by both PAb 240 and 246 since binding to DNA exposes p53's hydrophobic core domain within which resides the PAb 240 epitope (Halazonetis et al., 1993; McLure and Lee, 1996) .
To study the process of activation of p53 in more detail, we adopted a genetic approach designed to select for mutations in the pathways that lead to p53 activation. Cells containing a high copy number of the temperature sensitive p53 val135 (tsp53) gene and expressing large quantities of the protein were mutagenized. Cells that were resistant to the growth inhibitory properties of wild-type p53 induced by incubating at the permissive temperature of 328C, were selected and characterized. Interestingly, we found that the most frequent change in the mutagenized cells was cytoplas-mic sequestration of the tsp53 protein. Moreover, we determined that conformation and localization of p53 in the ALTR cells at 328C was strongly correlated. Our data suggests that the subcellular location of wild-type p53 and its conformation are closely linked events involved in the activation of p53.
Results

Selection of mutant A1-5 cells capable of growth at 328C
We selected A1-5 cells for mutagenesis because they have been extensively characterized previously and they contain a large number of copies of the tsp53 val135 gene which is constitutively expressed (Martinez et al., 1991) . At 328C, the p53 in A1-5 cells assumes a wildtype conformation and is translocated into the nucleus, where it binds DNA and causes growth arrest by inducing p21. However, at 398C, the restrictive temperature for p53 function, the p53 is sequestered in the cytoplasm in a mutant conformation, thus allowing for the proliferation of A1-5 cells at this temperature. Since A1-5 cells have multiple copies of the temperature sensitive p53 gene transfected into them, they were an ideal system in which we could force mutations in genes involved in the activation of p53 rather than p53 itself. To derive such variant cell lines that were incapable of activating p53, A1-5 cells were chemically mutagenized with EMS and clones capable of growth at 328C, the permissive temperature for p53 activation in A1-5 cells, were selected. Twentyeight of 40 cell lines picked were expanded and labeled ALTR 1 through 28, for A1-5 Low Temperature Resistant, of which 22 cell lines have been successfully maintained at 328C. Unlike the A1-5 parent cells, most of the ALTR cell lines were capable of vigorous growth at 328C, the permissive temperature for p53 activation. Moreover, this phenotype was stable since ALTR cells could be grown at 398C for an extended period of time, then returned to 328C, and still retained their ability for growth at this lower temperature. To con®rm that the p53 in the ALTR cells had not acquired mutations during the selection process, RT ± PCR and automated DNA sequence analysis of fulllength p53 was performed. No mutations were found in ALTRs 1, 17 and 25.
Localization of p53 in ALTR cells
The localization of p53 in A1-5 cells has been shown previously to follow a strict adherence to temperature sensitivity. At 328C, the p53 translocates into the nucleus while at 398C, the p53 is cytoplasmically sequestered. It was important to determine if the p53 in ALTR cells also maintained the same localization characteristics as the parent A1-5 cells at 328C. To determine the subcellular localization of p53 we performed indirect immuno¯uorescence using an antibody speci®c for p53 (PAb 421), on ALTR cells maintained at either 328C or 398C (Table 1) . Similar to parental A1-5 cells at 398C, most of the ALTR cell lines had cytoplasmically localized p53 (Table 1 and Figure 1 ). However, at 328C, all but four ALTR cell lines (ALTRs 9, 10, 17 and 18) still exhibited predominantly cytoplasmic p53 localization. Based on this subcellular localization data, we observed two classes of ALTR cells at 328C. Those with p53 predominantly sequestered in the cytoplasm, and those with predominantly nuclear p53. and 25 respectively, all of which were maintained at 328C. All photographs were taken using a 406objective lens
Conformation of p53 in ALTR cells is varied
Ability to bind DNA in a stable manner has been shown to be dependent on the conformation of p53 (McLure and Lee, 1999; Wolkowicz et al., 1998) . Wildtype p53 tetramers can bind DNA with enhanced stability compared to tetramers that have a mixture of wild-type and mutant p53 Lee, 1998, 1999) . The p53 in A1-5 cells is conformationallȳ exible depending on the temperature and at 328C it is predominantly in a wild-type conformation as recognized by PAb 246 (Figure 2 ). Our results with the localization of p53 in ALTR cells indicated a temperature independent subcellular localization pattern. To determine if the conformation of p53 in these cells was also temperature independent, we performed immunoprecipitation analysis using antibodies that recognize speci®c conformations of p53. Conformation of the p53 protein was examined in ALTR cells maintained at 328C by immunoprecipitation (IP) analysis using the conformation-speci®c antibodies PAb 246 (wild-type speci®c), PAb 240 (mutant speci®c) and PAb 421 (non-conformation speci®c) (Gamble and Milner, 1988; Gannon et al., 1990; Milner et al., 1987) . We compared the mutant and wild-type IP pro®le observed by A1-5 cells at 398 and 328C with that obtained for ALTR cells at 328C. The ratio of p53 immunoprecipitated by PAb 246 (wild-type speci®c) to PAb 240 (mutant speci®c) was used to determine the conformation of p53 in A1-5 and ALTR cells. A ratio of 1 or higher was considered a wild-type p53 conformation, consistent with p53 IP pro®les obtained in A1-5 cells at 328C. A PAb 246 : 240 ratio below 1 was considered a mutant conformation. Figure 2a represents the immunoprecipitation pro®les obtained for ALTRs 1, 17, 19 and 25 and Figure 2b shows the ratio of p53 immunoprecipitated by PAb 246 to 240. To our surprise, we found that the p53 in only four ALTR cell lines (ALTRs 9, 10, 17 and 18) was present in a wild-type conformation at 328C. The p53 protein in the remaining ALTR cell lines displayed a mutant phenotype, i.e., the p53 immunoprecipitated preferentially with the PAb 240 antibody similar to that observed with A1-5 cells grown at 398C. Co-immunoprecipitation of proteins such as hsc70 and mdm-2 was also observed to occur in a conformation-dependent manner, i.e., hsc70 co-precipitated with the mutant conformation of p53 (Zambetti and and mdm-2 with the wild-type conformation of p53 (Chen et al., 1993; Momand et al., 1992) (data not shown). Table 1 summarizes our results of the conformation analysis of p53 in 16 ALTR cell lines tested and their subcellular localization. As can be seen from this summary, there is a strong correlation in ALTR cells between the conformation of the p53 protein and its subcellular location. When p53 is in the cytoplasm, even at 328C, it is present in a mutant conformation, while nuclear localized p53 at the same temperature is found in a wild-type conformation. This is interesting since it suggests that the conformation of tsp53 in the ALTR cells is not dictated by temperature alone. This data leads us to believe that subcellular localization of p53 may play an important role in determining the conformation of p53.
Conformation of p53 changes in response to IR in A1-5 and SK-N-SH cells
Based on the correlation observed in ALTR cells indicating that the conformation of p53 was speci®c to its subcellular localization, we wanted to determine if changes in localization of p53 could cause a corresponding change in the conformation of p53 independent of a temperature shift. To determine if the p53 in A1-5 cells could undergo such a change in conformation in response to a stimulus other than temperature, we exposed A1-5 cells to 5 Gy Ionizing Radiation (IR). A1-5 cells were maintained at 398C for this experiment. We observed translocation of p53 into the nucleus at 2 h after exposure to IR by indirect immuno¯uores-cence ( Figure 3A ,B). This translocation was transient since it was not detectable 3 and 6 h post irradiation. In the absence of IR, at 398C, the p53 in these cells was in a predominantly mutant conformation. However, in response to IR, there was a 50% (approximate) increase in the 246+ conformation of p53 ( Figure 3B ).
Since the p53 in A1-5 and ALTR cells does have a point mutation at residue 135, it could aect the integrity of the protein and therefore alter the conformation of the protein as well. If in fact, the correlation between localization and conformation was true, we argued, we would be able to see it in a cell line expressing wild-type p53. However, in most cells expressing wild-type p53, the level of protein is undetectable due to a rapid turnover rate. Therefore, we decided to use a cell line, such as SK-N-SH, a neuroblastoma derived cell line, which expresses wildtype p53 determined by sequencing (Davido et al., 1992) which is cytoplasmically sequestered and more stable (Moll et al., 1996; Zaika et al., 1999) . We exposed SK-N-SH cells to 5 Gy IR and observed strong translocation of p53 into the nucleus within 3 h by indirect immuno¯uorescence using PAb 421 ( Figure  4A ). To determine the conformation of the p53 in these cells, we immunoprecipitated p53 using PAb 421, 240, 1620, and 419. PAb 421 recognizes both mutant and wild-type conformations of p53, PAb 240 is speci®c for the mutant conformation of p53 while PAb 1620 is speci®c for wild-type p53. PAb 419 is speci®c for large T-antigen of the SV-40 virus and was used as the isotype control antibody. In the absence of IR, p53 was observed by immunoprecipitation predominantly with the 421 and 240 antibodies ( Figure 4B ). However, after exposure to IR all three antibodies were able to immunoprecipitate p53. These results indicate that in the absence of IR, the p53 is in a predominantly mutant conformation, correlating with the cytoplasmic localization of p53 in these cells. However, upon exposure to IR, the p53 translocates into the nucleus where it assumes a wild-type conformation, which can then be immunoprecipitated by PAb 1620 antibody.
Conformation and localization are related but independent events
The ALTR cells were selected to have mutations in pathways that activate p53. To determine if conformation or localization was compromised in these cells in response to IR, we tested two cytoplasmically sequestered ALTR cell lines, ALTR 1 and 25 to determine their response. Both cells have cytoplasmically localized p53 at 328C in a predominantly mutant conformation. Upon exposure to IR, strong translocation of p53 was observed into the nucleus in ALTR 1 cells ( Figure 5A ). However, by immunoprecipitation analysis, we did not observe a signi®cant increase in the 246+ conformation of the protein in these cells ( Figure 5B ). This inability to undergo a change in the conformation of p53 despite nuclear localization of the protein may in fact be an additional defect in the ALTR 1 cells that leads to the inactivation of p53. Transcriptional induction by p53 of the down-stream target gene p21 was also not observed in ALTR 1 cells following IR exposure (data not shown).
Interestingly, the p53 in ALTR 25 cells did not translocate into the nucleus in response to IR ( Figure  5A ). Consistent with this, we did not observe a corresponding increase in the wild-type conformation of the p53 protein ( Figure 5C ). These results suggest that an integral component of the pathway responsible for the translocation of p53 into the nucleus has been aected in the ALTR 25 cells. Together, these results with ALTR 1 and 25 cells also suggest that translocation of p53 into the nucleus and the corresponding change to a wild-type conformation are independent events that p53 must undergo in order to be functionally active.
Discussion
Elimination of a functional p53 is a critical step in tumor development. Inactivation can occur either at the level of the gene, through mutation, or at the level of the protein, by interacting with viral antigens or other cellular proteins or by physical sequestration in an inappropriate subcellular compartment (Levine, 1997 S-Methionine containing medium for 2 h, followed by cell lysis and immunoprecipitation. Immunoprecipitated protein was resolved by SDS ± PAGE, and the dried gel exposed to ®lm for 48 h. Phosphoimager analysis was performed to determine the ratio of S-labeled p53 protein was performed by immunoprecipitation using PAb 421 (total p53), PAb 1620 (wild-type speci®c), PAb 240 (mutant speci®c) and PAb 419 (isotype control) antibodies. SK-N-SH cells were exposed to 5 Gy IR followed by 35 S-methionine labeling for 3 h. The labeled protein extracts were used for immunoprecipitation. Immunoprecipitated protein was resolved by SDS ± PAGE, and the dried gel exposed to ®lm for 48 h Momand et al., 1992; Schener et al., 1990) . Although the mutations that occur in the p53 gene have been well documented and the proteins which bind to p53 and inactivate it have been described, little is known about the dysfunction that leads to cytoplasmic sequestration and inactivation of p53 function by physical means.
Translocation of p53 into the nucleus is an integral event in the functional activation of p53. In the absence of its nuclear localization sequence (NLS), wild-type p53 is unable to translocate into the nucleus and is functionally inactive as a tumor suppressor (Shaulsky et al., 1990b (Shaulsky et al., , 1991b .
To gain insight into the relationship between nuclear localization and p53 function, we generated variant ALTR cell lines that contained high levels of the temperature sensitive p53 val135 protein, capable of growth at 328C, the permissive temperature for p53 activation. On determining the subcellular localization of p53 in these cell lines, we observed that most of the ALTR cell lines generated had cytoplasmically sequestered p53 even at 328C. Only four of 16 ALTR lines tested displayed nuclear localization of p53 at 328C, the characteristic pattern of localization observed in parent A1-5 cells from which these ALTR cell lines were derived. This predominance of ALTR cells with cytoplasmically sequestered p53 at 328C suggests that an important mechanism by which p53 is inactivated in these cells is by physically suppressing p53 from interacting with its target site, the genomic DNA in the nucleus. Even though cytoplasmic sequestration has been previously identi®ed as a mechanism by which wild-type p53 is inactivated in tumors, the mechanism by which this inactivation occurs is still largely unknown.
The conformation of p53 has been shown to change in a cell cycle speci®c manner (Milner, 1991a,b; Milner & Watson, 1990; Sabapathy et al., 1997; Shaulsky et al., 1991a) . In addition, spatial regulation of p53 during the cell cycle has also been reported (Shaulsky et al., 1990a) . The authors found an accumulation of p53 in the nucleus at the beginning of the S phase, after which it was maintained in the cytoplasmic compartment of the cell. This and other evidence indicates that wild-type p53 is involved in the regulation of the cell cycle, even in the absence of genotoxic stress. On further characterization of the ALTR cell lines we also found a strong correlation between the subcellular localization of p53 and its subsequent conformation.
Wild-type p53 can exist in two dierent conformations, mutant and wild-type, based on reactivity with conformation speci®c antibodies (Milner, 1991a) . The wild-type conformation of p53 correlates with growth suppression while the mutant conformation promotes cell proliferation in genotypically wild-type p53 expressing cells (Milner and Watson, 1990) . We observed two main classes of ALTR cell lines based on their relationship between the localization of p53 and its conformation. In the ®rst class, ALTR cells with predominantly cytoplasmically sequestered tsp53 at 328C also exhibited a predominantly mutant conformation of tsp53 as determined by the conformation speci®c antibody PAb 240. The second class included cell lines with tsp53 localized in the nucleus at 328C in which the tsp53 was maintained in a wild-type conformation, as recognized by PAb 246. We were able to isolate only four ALTR cell lines, ALTRs 9, 10, 17 and 18 that displayed characteristics of this second class. This correlation between the localization of p53 protein and its conformation was interesting primarily since the temperature-sensitive p53 val135 present in these cells has been described previously to display a strong temperature-dependent phenotype (Milner and Medcalf, 1990) . In vitro and in vivo studies indicate that p53 val135 folds into a wild-type conformation at 328C, however, in the ALTR cells in which p53 val135 was cytoplasmically localized at 328C, the p53 protein was still maintained in a predominantly mutant conformation. Only in cells with nuclear localized p53 was the p53 val135 also present in a wild-type conformation therefore suggesting that the subcellular location of p53 was an important determinant of its subsequent conformation.
The notion that conformation was determined by the subcellular localization was further supported by observing that a similar response could be observed to stimuli other than temperature in parental A1-5 cells. We found that the protein in A1-5 cells could, in fact, alter its conformation from mutant to wild-type in response to ionizing radiation when maintained at 398C. This is a novel ®nding indicating that the conformation of tsp53 val135 in A1-5 cells was not dictated by temperature alone. When we examined the correlation between p53 localization and conformation in SK-N-SH cells, a neuroblastoma cell line known to express bona-®de wild-type p53, we were surprised to ®nd that in untreated cells, very little p53 was recognizable by the wild-type conformation speci®c antibody PAb 1620. The p53 in these cells has been found by sequencing to be wild-type, cytoplasmically sequestered, and resistant to mdm-2 mediated degradation. Upon exposure to IR, we observed an increase in not only the total level of p53 in these cells, but also its detectability by PAb 1620, concurrent with the translocation of p53 into the nucleus. This is similar to what we observed in IR treated A1-5 cells and suggests that the existing p53 in these cells is cytoplasmically sequestered in the mutant conformation, and upon translocation into the nucleus p53 is induced to fold into the wild-type conformation.
Our results are consistent with the observations made by Zerrahn et al. (1992) who previously showed a similar correlation between the subcellular localization of p53 and its conformation. They found that cytoplasmically sequestered p53 was presented in a mutant conformation whereas p53 capable of translocating into the nucleus was folded in a wild-type conformation. However, in their system, the cytoplasmically localized mutant p53 was also found by sequencing to have mutations in the p53 gene. Their data suggests that genotypically mutant p53 is preferentially maintained in the cytoplasmic compartment of the cell. In contrast, our results suggest that wild-type p53 can have a 240+ conformation when in the cytoplasm and that genotoxic stress causes p53 to fold into the wild-type conformation and concentrate in the nucleus.
Although there is a strong correlation between translocation of p53 into the nucleus and a change in its conformation to wild-type, these events are independent of each other based on results we obtained upon irradiation of the two ALTR cell lines, ALTR 1 and 25. In ALTR 1 cells no considerable increase in the wild-type conformation of p53 was observed in spite of almost all of the protein translocating into the nucleus. This suggests that translocation of p53 into the nucleus is not sucient for mediating a change in the conformation of the protein. Changes in conformation of p53 may be mediated by post-translational mechanisms or by association with other proteins which allow p53 to fold appropriately, either of which may be mutated in the ALTR 1 cell line. Interestingly, in ALTR 25 cells, the p53 did not translocate into the nucleus in response to exposure to IR and also did not show a corresponding increase in the wild-type conformation of the p53 protein. These results indicate that these cells have a defect in either the translocation machinery for p53 or in the signaling pathway upstream of p53 which is responsible for triggering its nuclear translocation response.
Our results indicate that physical sequestration of p53 in the cytoplasm can be a potent mechanism for inactivating p53 and that the translocation process is closely linked to the protein's conformation. The panel of ALTR cells generated during this study will be important reagents for examining the mechanisms involved in regulating p53 subcellular localization. In particular, ALTR 1 and ALTR 25 cells will aid in dissecting the two closely linked processes of p53 activation which involve its translocation into the nucleus and its change in conformation from mutant to wild-type. In addition, cell lines such as ALTR 17 which have nuclear localized p53 in a wild-type conformation but is functionally inactive will prove valuable in understanding additional post-translational modi®cations that p53 must undergo to function as a transcription factor. We are currently characterizing the defects in the ALTR cells that lead to the inactivation of p53 in an attempt to understand its regulation. We expect our panel of ALTR cells to provide us with a deeper understanding of how p53 is regulated and its role in several signal transduction pathways.
Materials and methods
Cell culture, reagents and irradiation A1-5 cells are rat ®broblast cell lines transfected with multiple copies of the temperature-sensitive murine p53val 135 gene (Martinez et al., 1991) . A1-5 and ALTR cell lines were maintained in DMEM medium, containing 10% heat inactivated fetal bovine serum, 100 u/ml penicillin, and 100 mg/ml streptomycin (Gibco BRL, Gaithersburg, MD, USA) with 5% CO 2 . A1-5 cells were incubated at 378C unless otherwise noted, and ALTR cell lines at 32.58C. SK-N-SH, a neuroblastoma derived cell line, was grown in DMEM medium containing 15% heat inactivated fetal bovine serum, 2 mM L-Glutamine, 4 mM sodium pyruvate and 100 u/ml penicillin, and 100 mg/ml streptomycin (Gibco BRL, Gaithersburg, MD, USA). SK-N-SH cells were maintained at 378C, in 5% CO 2 . Antibodies speci®c for p53 were obtained from the following: PAb 1620, 1801 (Calbiochem), PAb 421, 240, 246 and 419 (kindly provided by Dr Arnold Levine). Cells were exposed to 5 Gy Ionizing Radiation using a 60 Co source at an average dose rate of 66 cGy/min.
Selection of low temperature resistant cell lines
Variant A1-5 cell lines capable of growing at 32.58C were derived by mutagenesis with ethyl methane sulfonate and selection at 32.58C. Brie¯y, two 150 cm 2¯a sks containing A1-5 cells (passage 9) at 90% con¯uence were mutagenized by incubating with 500 mg/ml of ethyl methane sulfonate (Sigma Chemical Co.) per milliliter of complete medium for 13 h at 378C. After mutagenesis was complete, the cell monolayers were rinsed 36with DMEM and the cells incubated for an additional 24 h at 378C in fresh complete medium. Subsequently, the cells were trypsinized from the¯asks and replated onto 20 10-cm dishes and incubated at 378C for an additional 16 h. Following this, the cultures were transferred to a 32.58C incubator and incubation at this temperature continued until colonies began to appear (approximately 3 weeks). Forty resistant colonies were selected, 22 of which were successfully expanded into stable cell lines.
RT ± PCR for p53
Reverse transcription of 2 g total RNA from A1-5 and ALTR cells was carried out using 0.5 mg Oligo(dT) 12 ± 18 , 2 mM dNTP mix, 1 mM DTT, 0.5 mM MgCl 2 , 106RT buer and 50 units Superscript II RT in a 20 ml reaction (Gibco BRL). Full length p53 was ampli®ed by dividing it into three parts, the ®rst 1/3 NH 2 domain, the middle DNA binding domain region, and the remaining 1/3 COOH domain. The NH 2 -domain of p53 was ampli®ed by PCR using 5'-ATGGAGGAGTCACAGTCGGATA-3' as the upstream primer and 5'-ATAACAGACTTGGCTGTCCCAG-3' as the reverse primer, to generate a PCR product of 366 bp. The DNA binding domain of p53 was ampli®ed by PCR with 2 ml of the above reaction. The upstream primer 5'-GCCAAGTCTGTTATGTGCA-3', and the reverse primer 5'-GAGGCGC-TTGTGCAGGTGG-3' were used to speci®-cally amplify 590 bp of the p53 cDNA which maps to the DNA binding domain. The ®nal 1/3 region was ampli®ed using 5'-AGAAAATTTCCGCAAAAAGGAA-3' as the forward primer and 5'-CCCCACTTTCTTGACCATTGTT-3' as the reverse primer, to give a PCR product of 330 bp. All regions were overlapping to ensure full sequence information. PCR conditions were: denaturation at 958C for 5 min, followed by 30 cycles of 948C for 40 s, 558C for 30 s and 728C for 1 min. The PCR products were separated on a 1% agarose gel, excised and extracted from the gel using the QIAQuick gel extraction kit (Qiagen). The product was then sequenced in both directions on an automated sequencer using the same primers.
Indirect immunofluorescence and image processing
Cells were plated onto coverslips at an approximate concentration of 2610 5 cells per 60 mm 2 plate. The plates were then incubated at the appropriate temperature for 12 ± 16 h. Coverslips with attached cells were rinsed three times in cold PBS (containing 3 mM KCl, 1 mM KH 2 PO 4 , 0.2 mM MgCl 2 , 137 mM NaCl, and 8 mM Na 2 HPO 4 , pH 7.5), and cells ®xed to the coverslips using methanol:acetone (1 : 1) for 5 min, at 7208C. Sample coverslips were allowed to air dry, stored at 7208C and rehydrated using cold PBS when ready to be stained. For A1-5 and ALTR cells, undiluted PAb 421 antibody supernatent (approx. 200 ml) was applied and the coverslips were incubated at room temperature for 1 h after which, they were rinsed three times with cold PBS. Goat antimouse antibody conjugated to FITC (Sigma Chemical Co.) at a 1 : 500 dilution was then applied for an incubation time of 30 min, at room temperature. Samples were washed three times with cold PBS, and mounted on standard glass slides using Mowiol mounting medium (Calbiochem). PAb 421 and Goat-anti-mouse Cy-3 conjugate at 1 : 100 dilution (KPL) were used as the primary and secondary antibodies respectively for indirect immuno¯uorescent staining of SK-N-SH cells. A Zeiss LSM-10 model confocal microscope was used for all observations. Digital images were collected on each series using identical brightness and contrast settings within each cell line.
Immunoprecipitation
Cells grown on 10 cm 2 plates to 90% con¯uency at the appropriate temperature were used to immunoprecipitate p53 using antibodies speci®c for its conformation. Brie¯y, cells were labeled with 200 mCi 35 S-Methionine (New England Nuclear, Boston, MA, USA) per plate in DMEM containing 10% FBS for 1 h after starving for 1 h with DMEM (Methionine-free) containing 10% dialyzed fetal bovine serum. Cells were lysed on ice for 10 min in 1 ml Lysis buer (50 mM Tris-Cl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 5% NP-40, 1 mM PMSF, and 1 mM aprotinin, leupeptin and pepstatin A) (Sigma Chemical Co.). The supernatant was retained and 30 ml of protein A-sephadex beads (Gibco BRL) was added and samples rotated for 30 min at 48C to eliminate non-speci®c binding.
After quantitation using a scintillation counter, 2 to 6610 6 c.p.m. of cell lysate were incubated with 100 ml of antibody (approx. 1 mg) and 30 ml ProA-Sephadex beads and the tubes rotated at 48C overnight. The beads were washed three times with 1 ml SNNTE buer (50 mM Tris, 5 mM EDTA, 5% sucrose, 1% NP-40 and 0.5 M NaCl, pH 7.4) and once with 1 ml RIPA buer (1% Sodium deoxycholate, 0.1% SDS in lysis buer). Samples were electrophoresed on a 10% denaturing polyacrylamide gel. Vacuum dried gels were exposed to ®lm (Kodak X-OMAT AR) for approximately 48 h before developing. Quantitation of 35 S-labeled p53 protein was done using either densitometry analysis using Scion Image software or by phosphoimager analysis using ImageQuant software.
In experiments where cells were exposed to ionizing radiation, cells were not starved in methionine-free medium, instead, labeling was carried out for 2 h for A1-5 and ALTR cells and 3 h for SK-N-SH cells immediately after exposure to IR.
